Literature DB >> 14637199

Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.

Olli T Pentikäinen1, Luca Settimo, Kari Keinänen, Mark S Johnson.   

Abstract

Molecular models were constructed, using the published X-ray structure of rat glutamate receptor 2 (GluR2), for the ligand-binding domains of the human (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA)- and kainate-selective ionotropic glutamate receptors (iGluRs): GluR1-7 and KA1-2. Based on the analysis of the known X-ray structures of GluR2 in complex with glutamate, kainate, and AMPA, we have constructed binding motifs (relative positioning of a ligand in the binding site and the physico-chemical interactions that take place) for selected agonist ligands and found explanations for ligand-binding selectivity to homomeric receptors among the different iGluRs. Even a single sequence difference can explain significant differences in ligand-binding affinities between two receptors. In total, there are seven residues surrounding the binding cavity that affect agonist selectivity: in GluR2, these residues are Pro478, Thr480, Leu650, Ser654, Thr686, Tyr702, and Met708. Each of these seven positions has been shown, or is predicted, to influence the presence of one or more water molecules that, when present, may form bridging hydrogen bonds between particular ligands and receptors. By using this knowledge it should be possible to design new selective agonist ligands with high affinity for any AMPA/kainate receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637199     DOI: 10.1016/j.bcp.2003.08.013

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.

Authors:  Kimberly A Mankiewicz; Anu Rambhadran; Mei Du; Gomathi Ramanoudjame; Vasanthi Jayaraman
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

3.  Ab initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid) and kainic acid (2S-(2 alpha, 3 beta, 4 beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid.

Authors:  Elise Champeil; Gloria Proni; Danielle Sapse
Journal:  J Mol Model       Date:  2009-02-21       Impact factor: 1.810

4.  Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.

Authors:  L Leanne Lash-Van Wyhe; Pekka A Postila; Koichi Tsubone; Makoto Sasaki; Olli T Pentikäinen; Ryuichi Sakai; Geoffrey T Swanson
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

5.  Exploring kainate receptor pharmacology using molecular dynamics simulations.

Authors:  Pekka A Postila; Geoffrey T Swanson; Olli T Pentikäinen
Journal:  Neuropharmacology       Date:  2009-09-06       Impact factor: 5.250

Review 6.  Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.

Authors:  Philip E Chen; David J A Wyllie
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

7.  Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.

Authors:  Mark L Mayer; Alokesh Ghosal; Nigel P Dolman; David E Jane
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.